糖皮质激素治疗脓毒血症的策略  

The Strategy of Glucocorticoid in the Treatment of Sepsis

作　　者：许东[1] 肖淼淼[1] 

机构地区：[1]华中科技大学同济医学院附属同济医院,湖北武汉430000

出　　处：《医学与哲学（B）》2014年第4期88-90,共3页Medicine & Philosophy(B)

基　　金：湖北省自然科学基金;项目编号:2013CFB077

摘　　要：脓毒症是由感染所致的破坏性的全身炎症反应综合征,进一步发展可导致多器官功能障碍综合征,甚至休克,成为危重患者最主要的死亡原因之一。糖皮质激素是脓毒症的重要辅助药物,其治疗机制在于其抑制机体的炎症反应,但其使用剂量、疗程、时间一直存在争议。本文通过回顾糖皮质激素在治疗脓毒症的发展历程,深入探讨糖皮质激素治疗脓毒血症的治疗策略。Sepsis is the systemic inflammatory response syndrome induced by infection ,which can develop into multiple organ dysfunction syndrome ,even shock ,which is the major cause of death in critically ill patients .Glucocorticoid is an important auxiliary drug for sepsis ,but its dosage ,course of treatment and time has been controversial by now .The mechanism of glucocorticoid in the treatment of sepsis is to inhibition the inflammatory response in the body .This article reviews the historical course and explores the therapeutic strategy of glucocorticoid in the treatment of sepsis .

关 键 词：糖皮质激素 脓毒症 治疗策略 

分 类 号：R02[医药卫生]